MicroRNA regulation of DNA repair gene expression in hypoxic stress.

MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab (2009) 3.30

miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. Mol Cell (2010) 3.27

Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer (2010) 2.95

Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A (2010) 2.91

MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle (2010) 2.18

MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One (2010) 2.05

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer. Transl Oncol (2010) 2.03

Hypoxic enhancement of exosome release by breast cancer cells. BMC Cancer (2012) 1.92

An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem (2009) 1.90

MiR-210--micromanager of the hypoxia pathway. Trends Mol Med (2010) 1.90

Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood. BMC Genomics (2010) 1.84

MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol (2011) 1.81

Generating specificity and diversity in the transcriptional response to hypoxia. Nat Rev Genet (2009) 1.76

miR-210: the master hypoxamir. Microcirculation (2012) 1.56

Cellular and molecular mechanisms underlying oxygen-dependent radiosensitivity. Radiat Res (2015) 1.53

Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications. Int J Mol Sci (2013) 1.50

Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther (2011) 1.50

MicroRNAs: new players in the DNA damage response. J Mol Cell Biol (2010) 1.46

Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci (2010) 1.45

microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. Am J Physiol Heart Circ Physiol (2011) 1.45

MiR-210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines. Cell Death Dis (2013) 1.37

Prioritization of disease microRNAs through a human phenome-microRNAome network. BMC Syst Biol (2010) 1.37

MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression. Mol Cancer Res (2011) 1.33

miRNA response to DNA damage. Trends Biochem Sci (2011) 1.32

Hypoxia: a master regulator of microRNA biogenesis and activity. Free Radic Biol Med (2013) 1.30

miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells. J Cell Physiol (2012) 1.29

Epigenetic Control of MicroRNA Expression and Aging. Curr Genomics (2009) 1.28

The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta (2012) 1.26

Trash or Treasure: extracellular microRNAs and cell-to-cell communication. Front Genet (2013) 1.25

Epigenetic alterations in aging. J Appl Physiol (1985) (2010) 1.20

A set of miRNAs participates in the cellular senescence program in human diploid fibroblasts. Cell Death Differ (2011) 1.19

The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PLoS One (2010) 1.18

Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF. PLoS One (2012) 1.18

MiR-205 silences MED1 in hypoxic primary human trophoblasts. FASEB J (2010) 1.17

Invited review: decoding the microRNA response to hypoxia. Pflugers Arch (2011) 1.12

Multiple functions of hypoxia-regulated miR-210 in cancer. J Exp Clin Cancer Res (2014) 1.12

MicroRNAs and DNA damage response: implications for cancer therapy. Cell Cycle (2012) 1.11

The cellular response to hypoxia: tuning the system with microRNAs. J Clin Invest (2010) 1.11

Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis (2012) 1.10

MicroRNAs in mental health: from biological underpinnings to potential therapies. Neuromolecular Med (2009) 1.09

MicroRNA regulons in tumor microenvironment. Oncogene (2014) 1.08

MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition. Cancer Res (2012) 1.07

miR-210 targets iron-sulfur cluster scaffold homologue in human trophoblast cell lines: siderosis of interstitial trophoblasts as a novel pathology of preterm preeclampsia and small-for-gestational-age pregnancies. Am J Pathol (2011) 1.06

Post-Transcriptional Control of the Hypoxic Response by RNA-Binding Proteins and MicroRNAs. Front Mol Neurosci (2011) 1.06

Hypoxic stress and cancer: imaging the axis of evil in tumor metastasis. NMR Biomed (2011) 1.06

Targeting hypoxic cells through the DNA damage response. Clin Cancer Res (2010) 1.04

Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin (2013) 1.04

Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms. Breast Cancer Res (2010) 1.03

Analysis of miRNA and mRNA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity. PLoS One (2012) 1.02

Gene expression and hypoxia in breast cancer. Genome Med (2011) 1.02

Survival of hypoxic human mesenchymal stem cells is enhanced by a positive feedback loop involving miR-210 and hypoxia-inducible factor 1. J Vet Sci (2013) 1.02

Elevated expression of miR-210 predicts poor survival of cancer patients: a systematic review and meta-analysis. PLoS One (2014) 1.01

MicroRNAs in skin and wound healing. Physiol Genomics (2010) 1.00

Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing. BMC Genomics (2014) 1.00

Integrated analysis of microRNA and mRNA expression and association with HIF binding reveals the complexity of microRNA expression regulation under hypoxia. Mol Cancer (2014) 0.98

MicroRNA-24 regulates the processing of latent TGFβ1 during cyclic mechanical stress in human trabecular meshwork cells through direct targeting of FURIN. J Cell Physiol (2011) 0.98

Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer. Expert Rev Mol Diagn (2011) 0.97

Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model. Br J Cancer (2013) 0.96

MicroRNA-31 contributes to colorectal cancer development by targeting factor inhibiting HIF-1α (FIH-1). Cancer Biol Ther (2014) 0.96

Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol (2014) 0.96

miR-210: fine-tuning the hypoxic response. Adv Exp Med Biol (2014) 0.95

Small players with big roles: microRNAs as targets to inhibit breast cancer progression. Curr Drug Targets (2010) 0.93

Tumor hypoxia and genetic alterations in sporadic cancers. J Obstet Gynaecol Res (2011) 0.93

Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer. PLoS One (2012) 0.93

Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment. DNA Repair (Amst) (2015) 0.93

HypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal (2013) 0.92

Genome-scale DNA methylation pattern profiling of human bone marrow mesenchymal stem cells in long-term culture. Exp Mol Med (2012) 0.92

Tumor hypoxia as a driving force in genetic instability. Genome Integr (2013) 0.92

ROD1 is a seedless target gene of hypoxia-induced miR-210. PLoS One (2012) 0.92

The role of hypoxia-induced miR-210 in cancer progression. Int J Mol Sci (2015) 0.91

MicroRNAs as Mediators of the Ageing Process. Genes (Basel) (2014) 0.91

The tumor microenvironment and DNA repair. Semin Radiat Oncol (2010) 0.91

MicroRNAs in cancer diagnosis and therapy: from bench to bedside. Surg Today (2012) 0.90

microRNAs in cancer cell response to ionizing radiation. Antioxid Redox Signal (2014) 0.90

The Role of miRNAs as Key Regulators in the Neoplastic Microenvironment. Mol Biol Int (2011) 0.90

Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis. Cell Death Dis (2014) 0.90

Tissue inhibitor of metalloproteinases-1 induces a pro-tumourigenic increase of miR-210 in lung adenocarcinoma cells and their exosomes. Oncogene (2014) 0.89

Angiogenesis-regulating microRNAs and Ischemic Stroke. Curr Vasc Pharmacol (2015) 0.89

A direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patients. Oncotarget (2015) 0.88

Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma. J Oncol (2015) 0.88

Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function. J Mol Med (Berl) (2012) 0.88

MicroRNAs as new maestro conducting the expanding symphony orchestra of regenerative and reparative medicine. Physiol Genomics (2011) 0.87

HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxid Redox Signal (2013) 0.87

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies. Int J Mol Sci (2016) 0.86

MicroRNAs as putative mediators of treatment response in prostate cancer. Nat Rev Urol (2012) 0.86

Noncoding RNAs in DNA repair and genome integrity. Antioxid Redox Signal (2013) 0.86

Hypoxia and DNA repair. Yale J Biol Med (2013) 0.86

microRNAs: The Short Link between Cancer and RT-Induced DNA Damage Response. Front Oncol (2014) 0.85

MicroRNA profiling in ischemic injury of the gracilis muscle in rats. BMC Musculoskelet Disord (2010) 0.85

Identification of a set of miRNAs differentially expressed in transiently TIA-depleted HeLa cells by genome-wide profiling. BMC Mol Biol (2013) 0.85

MicroRNA 107 partly inhibits endothelial progenitor cells differentiation via HIF-1β. PLoS One (2012) 0.85

The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review. Front Microbiol (2014) 0.84

MicroRNA response to hypoxic stress in soft tissue sarcoma cells: microRNA mediated regulation of HIF3α. BMC Cancer (2014) 0.84

MicroRNA and HER2-overexpressing cancer. Microrna (2013) 0.83

OxymiRs in cutaneous development, wound repair and regeneration. Semin Cell Dev Biol (2012) 0.83

A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas. Oncotarget (2015) 0.83

Insights on the functional interactions between miRNAs and copy number variations in the aging brain. Front Mol Neurosci (2013) 0.83

HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment. Sci Rep (2015) 0.83

MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer. Oncotarget (2016) 0.83

Over-expression of microRNA-494 up-regulates hypoxia-inducible factor-1 alpha expression via PI3K/Akt pathway and protects against hypoxia-induced apoptosis. J Biomed Sci (2013) 0.82

The human genome browser at UCSC. Genome Res (2002) 168.23

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87

Prediction of mammalian microRNA targets. Cell (2003) 53.70

Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47

miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res (2006) 39.25

miRBase: tools for microRNA genomics. Nucleic Acids Res (2007) 38.61

MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell (2007) 38.42

Human MicroRNA targets. PLoS Biol (2004) 34.51

c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81

The microRNA Registry. Nucleic Acids Res (2004) 29.45

The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev (2008) 15.01

MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics (2005) 11.75

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (1996) 10.14

HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J (1998) 10.08

A microRNA signature of hypoxia. Mol Cell Biol (2006) 7.24

MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38

The let-7 MicroRNA family members mir-48, mir-84, and mir-241 function together to regulate developmental timing in Caenorhabditis elegans. Dev Cell (2005) 5.90

Pervasive regulation of Drosophila Notch target genes by GY-box-, Brd-box-, and K-box-class microRNAs. Genes Dev (2005) 5.78

DNA strand exchange mediated by a RAD51-ssDNA nucleoprotein filament with polarity opposite to that of RecA. Cell (1995) 4.98

MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem (2008) 4.69

Gene regulation by microRNAs. Curr Opin Genet Dev (2006) 4.01

Glucose metabolism and cancer. Curr Opin Cell Biol (2006) 3.75

Synergistic actions of Rad51 and Rad52 in recombination and DNA repair. Nature (1998) 3.57

Human cancers express a mutator phenotype. Proc Natl Acad Sci U S A (2006) 3.11

Mammalian DNA mismatch repair. Annu Rev Genet (1999) 2.64

Genetic instability induced by the tumor microenvironment. Cancer Res (1996) 2.33

Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol (2003) 2.12

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol Cell Biol (2004) 2.09

Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res (2005) 2.02

Regulation of DNA repair in hypoxic cancer cells. Cancer Metastasis Rev (2007) 1.99

Stable binding of human XPC complex to irradiated DNA confers strong discrimination for damaged sites. J Mol Biol (2000) 1.79

Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia. Oncogene (2006) 1.68

Mutagenesis induced by the tumor microenvironment. Mutat Res (1998) 1.29

The transcription factor DEC1 (stra13, SHARP2) is associated with the hypoxic response and high tumour grade in human breast cancers. Br J Cancer (2004) 1.26

Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner. Cancer Res (2005) 1.24

Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network. Cancer Lett (2007) 1.14

Tumor progression: potential role of unstable genomic changes. Cancer Metastasis Rev (1990) 1.12

Autophagy and tumor suppression: recent advances in understanding the link between autophagic cell death pathways and tumor development. Adv Exp Med Biol (2008) 1.06

Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer. Cancer Sci (2006) 1.05

The Drosophila nerfin-1 mRNA requires multiple microRNAs to regulate its spatial and temporal translation dynamics in the developing nervous system. Dev Biol (2007) 0.95

A microRNA signature of hypoxia. Mol Cell Biol (2006) 7.24

Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science (2002) 3.86

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet (2002) 3.04

Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol Cell Biol (2003) 2.12

Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol Cell Biol (2004) 2.09

MicroRNA-210 regulates mitochondrial free radical response to hypoxia and krebs cycle in cancer cells by targeting iron sulfur cluster protein ISCU. PLoS One (2010) 2.05

Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res (2005) 2.02

Regulation of DNA repair in hypoxic cancer cells. Cancer Metastasis Rev (2007) 1.99

Hypoxia response and microRNAs: no longer two separate worlds. J Cell Mol Med (2008) 1.93

An integrated approach for experimental target identification of hypoxia-induced miR-210. J Biol Chem (2009) 1.90

Analysis of microRNA transcriptome by deep sequencing of small RNA libraries of peripheral blood. BMC Genomics (2010) 1.84

miR-210: More than a silent player in hypoxia. IUBMB Life (2011) 1.74

Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance. Cancer Res (2008) 1.70

Hypoxia-induced genetic instability--a calculated mechanism underlying tumor progression. J Mol Med (Berl) (2006) 1.66

Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302. Mol Cancer Ther (2011) 1.58

Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin Biol Ther (2007) 1.57

Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther (2011) 1.50

Regulation of microRNA expression: the hypoxic component. Cell Cycle (2007) 1.49

Human XPA and RPA DNA repair proteins participate in specific recognition of triplex-induced helical distortions. Proc Natl Acad Sci U S A (2002) 1.49

Inhibition of poly(ADP-ribose) polymerase down-regulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proc Natl Acad Sci U S A (2010) 1.47

microRNA: emerging therapeutic targets in acute ischemic diseases. Pharmacol Ther (2009) 1.45

Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat Res (2005) 1.37

Repair of DNA lesions associated with triplex-forming oligonucleotides. Mol Carcinog (2009) 1.36

Site-directed recombination via bifunctional PNA-DNA conjugates. Proc Natl Acad Sci U S A (2002) 1.32

Correction of a splice-site mutation in the beta-globin gene stimulated by triplex-forming peptide nucleic acids. Proc Natl Acad Sci U S A (2008) 1.25

Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner. Cancer Res (2005) 1.24

Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Radiother Oncol (2005) 1.22

Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6. Carcinogenesis (2006) 1.19

The potential for gene repair via triple helix formation. J Clin Invest (2003) 1.19

Hypoxic tumor microenvironment and cancer cell differentiation. Curr Mol Med (2009) 1.19

Site-specific gene modification by PNAs conjugated to psoralen. Biochemistry (2006) 1.16

Emerging roles of microRNAs in the molecular responses to hypoxia. Curr Pharm Des (2009) 1.14

Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network. Cancer Lett (2007) 1.14

Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol Cell Biol (2011) 1.13

Nanoparticles deliver triplex-forming PNAs for site-specific genomic recombination in CD34+ human hematopoietic progenitors. Mol Ther (2010) 1.13

Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites. Cancer Biol Ther (2006) 1.09

Triplex-forming oligonucleotides: principles and applications. Q Rev Biophys (2002) 1.09

Targeting cancer with a lupus autoantibody. Sci Transl Med (2012) 1.09

Triplex-forming oligonucleotides as potential tools for modulation of gene expression. Curr Med Chem Anticancer Agents (2005) 1.08

microRNAs in cancer: from bench to bedside. Adv Cancer Res (2010) 1.08

Post-Transcriptional Control of the Hypoxic Response by RNA-Binding Proteins and MicroRNAs. Front Mol Neurosci (2011) 1.06

Targeted disruption of the CCR5 gene in human hematopoietic stem cells stimulated by peptide nucleic acids. Chem Biol (2011) 1.05

MicroRNA-191, an estrogen-responsive microRNA, functions as an oncogenic regulator in human breast cancer. Carcinogenesis (2013) 1.04

Repair and recombination induced by triple helix DNA. Front Biosci (2007) 1.04

Cell-interdependent cisplatin killing by Ku/DNA-dependent protein kinase signaling transduced through gap junctions. Proc Natl Acad Sci U S A (2004) 1.03

Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms. Breast Cancer Res (2010) 1.03

Dihydroceramide-based response to hypoxia. J Biol Chem (2011) 1.02

Repair of DNA interstrand cross-links: interactions between homology-dependent and homology-independent pathways. DNA Repair (Amst) (2006) 1.02

Potentiation of temozolomide cytotoxicity by inhibition of DNA polymerase beta is accentuated by BRCA2 mutation. Cancer Res (2009) 1.02

Targeted gene modification of hematopoietic progenitor cells in mice following systemic administration of a PNA-peptide conjugate. Mol Ther (2011) 1.01

Impact of APE1/Ref-1 redox inhibition on pancreatic tumor growth. Mol Cancer Ther (2011) 1.00

Peptide conjugates for chromosomal gene targeting by triplex-forming oligonucleotides. Nucleic Acids Res (2004) 0.98

PDGF induced microRNA alterations in cancer cells. Nucleic Acids Res (2011) 0.97

Functional and physical interaction between the mismatch repair and FA-BRCA pathways. Hum Mol Genet (2011) 0.97

Interplay between DNA repair and inflammation, and the link to cancer. Crit Rev Biochem Mol Biol (2014) 0.96

Alterations in DNA repair gene expression under hypoxia: elucidating the mechanisms of hypoxia-induced genetic instability. Ann N Y Acad Sci (2005) 0.96

Proteasome-dependent regulation of signal transduction in retinal pigment epithelial cells. Exp Eye Res (2006) 0.95

Targeted genome modification via triple helix formation. Ann N Y Acad Sci (2005) 0.95

Triplex-stimulated intermolecular recombination at a single-copy genomic target. Mol Ther (2006) 0.95

Dichloroacetate reverses the hypoxic adaptation to bevacizumab and enhances its antitumor effects in mouse xenografts. J Mol Med (Berl) (2013) 0.95

Gene therapy for autosomal dominant disorders of keratin. J Investig Dermatol Symp Proc (2005) 0.94

Targeted correction of a thalassemia-associated beta-globin mutation induced by pseudo-complementary peptide nucleic acids. Nucleic Acids Res (2009) 0.93

Src-Induced cisplatin resistance mediated by cell-to-cell communication. Cancer Res (2009) 0.93

Distance and affinity dependence of triplex-induced recombination. Biochemistry (2005) 0.93

HypoxamiRs and cancer: from biology to targeted therapy. Antioxid Redox Signal (2013) 0.92

Analysis of the microRNA transcriptome and expression of different isomiRs in human peripheral blood mononuclear cells. BMC Res Notes (2013) 0.91

The tumor microenvironment and DNA repair. Semin Radiat Oncol (2010) 0.91

CHK2-dependent phosphorylation of BRCA1 in hypoxia. Radiat Res (2006) 0.91

microRNAs in cancer cell response to ionizing radiation. Antioxid Redox Signal (2014) 0.90

AMP-activated protein kinase is essential for survival in chronic hypoxia. Biochem Biophys Res Commun (2008) 0.89

Triplex-induced recombination and repair in the pyrimidine motif. Nucleic Acids Res (2005) 0.89

Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumors. Int J Radiat Biol (2011) 0.89

Transcription dependence of chromosomal gene targeting by triplex-forming oligonucleotides. J Biol Chem (2002) 0.89

Clinico-hematological profile of congenital leukemia. Indian J Pediatr (2004) 0.88

Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance. Cancer Lett (2006) 0.88

Analysis of von Hippel-Lindau hereditary cancer syndrome: implications of oxygen sensing. Methods Enzymol (2004) 0.87

Reduced level of ribonucleotide reductase R2 subunits increases dependence on homologous recombination repair of cisplatin-induced DNA damage. Mol Pharmacol (2011) 0.87

Characterization of phosphorylation sites on Tpl2 using IMAC enrichment and a linear ion trap mass spectrometer. J Proteome Res (2007) 0.86

Triplex-mediated gene modification. Methods Mol Biol (2008) 0.86

Site-directed gene mutation at mixed sequence targets by psoralen-conjugated pseudo-complementary peptide nucleic acids. Nucleic Acids Res (2007) 0.86

Hypoxia-induced protein CAIX is associated with somatic loss of BRCA1 protein and pathway activity in triple negative breast cancer. Breast Cancer Res Treat (2012) 0.86

Identification of Elongin C and Skp1 sequences that determine Cullin selection. J Biol Chem (2004) 0.85

Targeted gene modification using triplex-forming oligonucleotides. Methods Mol Biol (2004) 0.85

Combined miRNA and mRNA signature identifies key molecular players and pathways involved in chikungunya virus infection in human cells. PLoS One (2013) 0.84

The interplay of HuR and miR-3134 in regulation of AU rich transcriptome. RNA Biol (2013) 0.84

Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide. Biochemistry (2006) 0.84

IGF1 receptor expression protects against microenvironmental stress found in the solid tumor. Radiat Res (2002) 0.84

Site-specific Genome Editing in PBMCs With PLGA Nanoparticle-delivered PNAs Confers HIV-1 Resistance in Humanized Mice. Mol Ther Nucleic Acids (2013) 0.83

Molecular markers in clinical radiation oncology. Oncogene (2003) 0.82

Polymer delivery systems for site-specific genome editing. J Control Release (2011) 0.82

MEN1 and FANCD2 mediate distinct mechanisms of DNA crosslink repair. DNA Repair (Amst) (2008) 0.82

Mlh1-dependent suppression of specific mutations induced in vivo by the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP). Mutat Res (2005) 0.81

Bronchioloalveolar cell carcinoma presenting as a "non-resolving consolidation" for two years. Pneumonol Alergol Pol (2015) 0.81

Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5. Artif DNA PNA XNA (2013) 0.80

miR-22 regulates expression of oncogenic neuro-epithelial transforming gene 1, NET1. FEBS J (2014) 0.80

Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer. Mol Cancer Ther (2012) 0.79

Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung. Adv Healthc Mater (2014) 0.79

"Micro"-management of DNA repair genes by hypoxia. Cell Cycle (2009) 0.77